Large sample study validates a quality of life instrument for chronic diseases, suggesting it aids treatment planning.
QLICD-GM(V2.0) provides a psychometrically sound, clinically interpretable and responsive measure of generic QoL in chronic patients. It can be used alone or combined with disease-specific modules to monitor benefit and guide treatment and rehabilitation planning.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: